CROX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CROX is not a clear buy right now for a Beginner with a long-term horizon and $50,000-$100,000 to deploy. The stock has some positive long-term elements, but the current setup is mixed: trend is only modestly constructive, short-term momentum is not strong, and the latest quarter showed weaker revenue, earnings, and margins even though results beat expectations. Given the investor profile, the better decision is to hold off rather than buy immediately.
Price is 103.765, slightly below the previous close of 104.08 after a -1.58% regular-session decline. Trend structure remains positive because SMA_5 > SMA_20 > SMA_200, which supports an uptrend. However, MACD histogram is -0.616 and below zero, showing momentum has weakened. RSI_6 at 54.769 is neutral, so there is no oversold buy signal. Key levels: pivot 102.403, resistance at 106.941 and 109.745, support at 97.865 and 95.061. Overall, the chart is still constructive but not strong enough to call it an immediate buy.
Q1 revenue of $921.5M beat expectations; adjusted EPS of $2.99 also beat estimates. International growth was strong, especially in China, India, and Japan. Management expects high single-digit to near double-digit international growth. Hedge funds are buying aggressively, with buying up 599.85% over the last quarter. Several analysts raised price targets after Q1 and some turned more constructive, including Seaport upgrading to Buy.
Latest quarter still showed revenue down 1.69% YoY, net income down 14.08% YoY, EPS down 4.24% YoY, and gross margin down 1.78% YoY. Tariffs and macro cost pressures remain an overhang. The short-term stock pattern suggests weakness, with modeled downside over the next day/week/month. No signal from AI Stock Picker or SwingMax today. Insider activity is neutral and there is no recent congress trading data.
In Q1 2026, Crocs posted revenue of $921.5M, down 1.69% year over year, so top-line growth is still negative despite beating estimates. Net income fell 14.08% YoY to $137.6M, EPS declined 4.24% YoY to $2.71, and gross margin slipped to 56.75%, down 1.78 points. The latest quarter season is Q1 2026. The beat-versus-expectations outcome is positive, but the underlying growth trend remains soft.
Recent analyst action has improved, with multiple target raises after Q1. UBS raised its target to $107 and stayed Neutral; Baird raised to $115 and stayed Neutral; BofA raised to $125 and kept Buy; Barclays raised to $110 and stayed Equal Weight; Seaport upgraded to Buy with a $135 target; Williams Trading upgraded to Buy with a $116 target. Wall Street is divided: the pros see improving demand, better visibility, and possible multiple expansion, but the cautious camp still points to execution risk, weak HeyDude demand, and uncertainty around a durable growth inflection.
